Literature DB >> 23091264

Inflammation in abdominal aortic aneurysms: cellular infiltrate and cytokine profiles.

Matthew J Eagleton1.   

Abstract

Abdominal aortic aneurysm (AAA) pathogenesis occurs as a result of the altered homeostasis of the aortic vessel wall structural proteins. This results in weakening, and subsequent expansion, of the aorta leading to aneurysm formation. Multiple mechanisms are involved in this process, including genetic abnormalities, biomechanical wall stress, apoptosis, and proteolytic degradation of the aortic wall. One key hallmark of this pathology, which orchestrates the interaction of the various pathologic processes, is inflammation. The inflammatory process is characterized by the infiltration of a variety of cells, which leads to the upregulation of multiple cytokines. The balance of the cellular type and resultant cytokine milieu determines the ultimate fate of the aortic wall - healing, atherosclerosis or aneurysm formation. This review highlights some of the known cellular and cytokine inflammatory events that are involved in aortic aneurysm formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23091264     DOI: 10.1258/vasc.2011.201207

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  21 in total

1.  Human Adipose-Derived Stem Cells Suppress Elastase-Induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion Through Paracrine Factors.

Authors:  Jie Xie; Thomas J Jones; Dongni Feng; Todd G Cook; Andrea A Jester; Ru Yi; Yameena T Jawed; Clifford Babbey; Keith L March; Michael P Murphy
Journal:  Cell Transplant       Date:  2016-07-18       Impact factor: 4.064

2.  Identification and characterization of CD4(+)AT2(+) T lymphocyte population in human thoracic aortic aneurysm.

Authors:  Chenxi Wang; Ting Wu; Xiaojuan Hu; Ritai Huang; Feng Lian; Weijun Wang; Yuan Feng; Bo Xie; Zhenlei Hu; Xinming Zhai; Jidong Liu; Jianmin Gu; Yao Chen; Jun Li; Song Xue
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

3.  FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Authors:  Guillermo Moñux; Jose J Zamorano-León; Pablo Marqués; Bernardo Sopeña; J M García-García; G Laich de Koller; Bibiana Calvo-Rico; Miguel A García-Fernandez; J Serrano; Antonio López-Farré
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

4.  Nicotine-induced upregulation of VCAM-1, MMP-2, and MMP-9 through the α7-nAChR-JNK pathway in RAW264.7 and MOVAS cells.

Authors:  Zong-Zhuang Li; Zhen-Zhen Guo; Zhi Zhang; Qun-An Cao; Ya-Juan Zhu; Hua-Li Yao; Li-Li Wu; Qiu-Yan Dai
Journal:  Mol Cell Biochem       Date:  2014-11-09       Impact factor: 3.396

5.  PPAR-γ agonist attenuates inflammation in aortic aneurysm patients.

Authors:  Tatsuo Motoki; Hirotsugu Kurobe; Yoichiro Hirata; Taisuke Nakayama; Hajime Kinoshita; Kevin A Rocco; Hitoshi Sogabe; Takaki Hori; Masataka Sata; Tetsuya Kitagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-27

6.  Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Authors:  Yasuhiko Kubota; Aaron R Folsom; Kunihiro Matsushita; David Couper; Weihong Tang
Journal:  Atherosclerosis       Date:  2017-10-13       Impact factor: 5.162

7.  Increased risk for subarachnoid hemorrhage in patients with sleep apnea.

Authors:  Sebastian Zaremba; Luca Albus; Patrick Schuss; Hartmut Vatter; Thomas Klockgether; Erdem Güresir
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

8.  Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.

Authors:  Yuanyuan Li; Gangsheng Lu; Dating Sun; Houjuan Zuo; Dao Wen Wang; Jiangtao Yan
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

9.  Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility.

Authors:  Letizia Scola; Federica M Di Maggio; Loredana Vaccarino; Manuela Bova; Giusy I Forte; Calogera Pisano; Giuseppina Candore; Giuseppina Colonna-Romano; Domenico Lio; Giovanni Ruvolo; Carmela R Balistreri
Journal:  Mediators Inflamm       Date:  2014-02-24       Impact factor: 4.711

Review 10.  Inflammatory diseases of the aorta: Part 1: Non-infectious aortitis.

Authors:  I Töpel; N Zorger; M Steinbauer
Journal:  Gefasschirurgie       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.